-
EP1730103
European procedure
Extract from the Register of European Patents
EP About this file: EP1730103
| EP1730103 - FORMAMIDE DERIVATIVES USEFUL AS ADRENOCEPTOR [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 01.04.2011 Database last updated on 09.09.2024 | Most recent event Tooltip | 01.04.2011 | No opposition filed within time limit | published on 04.05.2011 [2011/18] | Applicant(s) | For:GB
Pfizer Limited Ramsgate Road Sandwich, Kent CT13 9NJ / GB | For:AT
BE
BG
CH
CY
CZ
DE
DK
EE
ES
FI
FR
GR
HU
IE
IS
IT
LI
LT
LU
MC
NL
PL
PT
RO
SE
SI
SK
TR
Pfizer Inc. 235 East 42nd Street New York, NY 10017 / US | [2010/21] |
| Former [2006/50] | For:GB
Pfizer Limited Ramsgate Road Sandwich, Kent CT13 9NJ / GB | ||
| For:AT
BE
BG
CH
CY
CZ
DE
DK
EE
ES
FI
FR
GR
HU
IE
IS
IT
LI
LT
LU
MC
NL
PL
PT
RO
SE
SI
SK
TR
PFIZER INC. 235 East 42nd Street New York, N.Y. 10017 / US | Inventor(s) | 01 /
BROWN, Alan, Daniel Pfizer Global Research&Development, Ramsgate Road Sandwich, Kent CT13 9NJ / GB | 02 /
BUNNAGE, Mark, Edward Pfizer Global Research&Development, Ramsgate Road Sandwich, Kent CT13 9NJ / GB | 03 /
GLOSSOP, Paul, Alan Pfizer Global Research&Development, Ramsgate Road Sandwich, Kent CT13 9NJ / GB | 04 /
JAMES, Kim Pfizer Global Research&Development, Ramsgate Road Sandwich, Kent CT13 9NJ / GB | 05 /
LANE, Charlotte, Alice, Louise Pfizer Global Research&Development, Ramsgate Road Sandwich, Kent CT13 9NJ / GB | 06 /
LEWTHWAITE, Russell, Andrew Pfizer Global Research&Development, Ramsgate Road Sandwich, Kent CT13 9NJ / GB | 07 /
PRICE, David, Anthony Pfizer Global Research&Development, Ramsgate Road Sandwich, Kent CT13 9NJ / GB | [2006/50] | Representative(s) | Pringot, Thomas, et al ATTENTION: ADDRESS INACTIVE - USE ASS-NR - CDR / FR | [N/P] |
| Former [2009/21] | Pringot, Thomas, et al Pfizer Limited European Patent Department Ramsgate Road Sandwich, Kent CT13 9NJ / GB | ||
| Former [2009/20] | Pringot, Thomas, et al Pfizer Limited European Patent Department Ramsgate Road Sandwich, Kent CT13 9NJ / FR | ||
| Former [2006/50] | Pringot, Thomas Pfizer European Patent Department 23/25 avenue du Docteur Lannelongue F-75668 Paris Cedex 14 / FR | Application number, filing date | 05708714.0 | 10.03.2005 | [2006/50] | WO2005IB00619 | Priority number, date | EP20040290767 | 23.03.2004 Original published format: EP 04290767 | GB20040025054 | 12.11.2004 Original published format: GB 0425054 | [2006/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005092840 | Date: | 06.10.2005 | Language: | EN | [2005/40] | Type: | A1 Application with search report | No.: | EP1730103 | Date: | 13.12.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.10.2005 takes the place of the publication of the European patent application. | [2006/50] | Type: | B1 Patent specification | No.: | EP1730103 | Date: | 26.05.2010 | Language: | EN | [2010/21] | Search report(s) | International search report - published on: | EP | 06.10.2005 | Classification | IPC: | C07C233/43, C07C217/60, A61K31/135 | [2006/50] | CPC: |
C07C237/20 (EP,US);
A61P11/06 (EP);
A61P37/08 (EP);
C07C237/30 (EP,US);
C07C237/32 (EP,US);
C07C255/60 (EP,US);
C07C311/37 (EP,US);
C07C311/46 (EP,US);
C07C317/32 (EP,US);
C07C323/32 (EP,US);
C07C323/41 (EP,US);
C07C323/42 (EP,US);
C07D209/48 (EP,US);
C07D211/32 (EP,US);
C07D213/38 (EP,US);
C07D213/40 (EP,US);
C07D217/06 (EP,US);
C07D217/16 (EP,US);
C07D221/22 (EP,US);
C07D221/24 (EP,US);
C07D295/192 (EP,US);
C07D335/02 (EP,US);
C07C2601/14 (EP,US);
C07C2602/08 (EP,US);
C07C2603/74 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/50] | Extension states | AL | 23.10.2006 | BA | 23.10.2006 | HR | 23.10.2006 | LV | 23.10.2006 | MK | 23.10.2006 | YU | 23.10.2006 | Title | German: | ALS ADRENOZEPTOR GEEIGNETE FORMAMIDDERIVATE | [2006/50] | English: | FORMAMIDE DERIVATIVES USEFUL AS ADRENOCEPTOR | [2006/50] | French: | DERIVES DU FORMAMIDE UTILE COMME ADRENOCEPTEUR | [2009/49] |
| Former [2006/50] | DERIVES DU FORMAMIDE UTILE COMME ADRENOCEPTOR | Entry into regional phase | 23.10.2006 | National basic fee paid | 23.10.2006 | Designation fee(s) paid | 23.10.2006 | Examination fee paid | Examination procedure | 16.03.2005 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 07.09.2006 | Amendment by applicant (claims and/or description) | 23.10.2006 | Examination requested [2006/50] | 22.02.2007 | Despatch of a communication from the examining division (Time limit: M04) | 04.04.2007 | Reply to a communication from the examining division | 04.04.2008 | Despatch of a communication from the examining division (Time limit: M04) | 22.05.2008 | Reply to a communication from the examining division | 04.12.2009 | Communication of intention to grant the patent | 11.03.2010 | Fee for grant paid | 11.03.2010 | Fee for publishing/printing paid | Opposition(s) | 01.03.2011 | No opposition filed within time limit [2011/18] | Fees paid | Renewal fee | 02.04.2007 | Renewal fee patent year 03 | 31.03.2008 | Renewal fee patent year 04 | 31.03.2009 | Renewal fee patent year 05 | 31.03.2010 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]ES2005492 (LASA LAB [ES]) [Y] 1-20 * page 1, lines 2-8 * * claim 1 *; | [Y]CH686869 (SEPRACOR INC [US]) [Y] 1-20 * page 1, lines 1-20 * * page 5, lines 24-62 * * claim 1 *; | [Y]EP1235787 (THERAVANCE INC [US]) [Y] 1-20 * page 1, lines 6-11 * * claim 1 *; | [YD]WO03042160 (THERAVANCE INC [US], et al) [YD] 1-20 * page 1, lines 10-14 ** claim 1 *; | [YD]US2004006102 (MORAN EDMUND J [US], et al) [YD] 1-20 * page 1, paragraph 2 * * claim 1 * |